Cyclopharm Secures Major US Expansion Deal with University of Pennsylvania Health System
Cyclopharm has secured a multi-site agreement to supply its Technegas lung imaging platform to the University of Pennsylvania Health System across eleven locations in Pennsylvania and New Jersey. The deal includes immediate installations at University of Pennsylvania Hospital and Perelman Centre for Advanced Medicine, with nine additional sites to follow. This represents a significant milestone in Cyclopharm's US expansion strategy. Revenue will flow through equipment installations, annual support fees, and recurring per-patient consumable usage. Technegas is a diagnostic imaging solution for evaluating lung ventilation and function, with applications spanning pulmonary embolism diagnosis, chronic obstructive pulmonary disease, asthma, and pulmonary hypertension treatment.
